Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03753464 · ClinicalTrials.gov registry record
The Role of Functional Epigenetic Modifications in Peri-Implantitis
A clinical trial, sponsored by NYU College of Dentistry.
- Completed
- Registry status
- 15
- Enrollment target
NCT03753464: Completed study, sponsored by NYU College of Dentistry.
NCT03753464 is a clinical trial that has completed, run by NYU College of Dentistry. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03753464 has completed, sponsored by NYU College of Dentistry.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The aim of this pilot, exploratory, single blind clinical trial is to evaluate the epigenetic changes associated with peri-implantitis.
Primary Outcome
Gingival and blood samples collected from healthy subjects and subjects with peri-implantitis will be used to determinate epigenetic signatures associated with peri-implantitis.
Interventions
- PROCEDURE Gingival biopsy and blood sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2019-07-02 |
What the finished NCT03753464 record still lists
NCT03753464 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gingival biopsy and blood sample collection is the first listed.
NCT03753464 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03753464 about?
NCT03753464 is a clinical study titled "The Role of Functional Epigenetic Modifications in Peri-Implantitis". The aim of this pilot, exploratory, single blind clinical trial is to evaluate the epigenetic changes associated with peri-implantitis.
What is the current status of trial NCT03753464?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-10-04. Estimated completion is 2019-07-02.
What interventions are being tested in trial NCT03753464?
The interventions under investigation include: Gingival biopsy and blood sample collection (PROCEDURE).
Who is sponsoring clinical trial NCT03753464?
This trial is sponsored by NYU College of Dentistry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI